Merck & Co Current Liabilities
The Current Liabilities of Merck & Co (MRK) as of Sep 10, 2026 is 28.33 B USD. In the previous year, Current Liabilities was 41.99 B USD — a change of -32.53% (lower).
Get this data via API
Financial Data API
Current Liabilities
28.33 BUSD
YoY
-32.53%
Last updated:
The Merck & Co Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 28.33 BUSD | -32.53% | |
| 41.99 BUSD | +6.00% | |
| 39.61 BUSD | +4.77% | |
| 37.81 BUSD | -2.86% | |
| 38.92 BUSD | -13.96% | |
| 45.24 BUSD | +20.48% | |
| 37.55 BUSD | +5.42% | |
| 35.62 BUSD | +14.06% | |
| 31.23 BUSD | +21.49% | |
| 25.70 BUSD | -18.15% | |
| 31.40 BUSD | +4.91% | |
| 29.93 BUSD | -4.92% | |
| 31.48 BUSD | +0.90% | |
| 31.20 BUSD | +12.95% | |
| 27.62 BUSD | +9.13% | |
| 25.31 BUSD | +0.49% | |
| 25.19 BUSD | -1.63% | |
| 25.61 BUSD | +16.40% | |
| 22.00 BUSD | +8.17% | |
| 20.34 BUSD | -4.42% | |
| 21.28 BUSD | +15.93% | |
| 18.36 BUSD | +28.99% | |
| 14.23 BUSD | -26.69% | |
| 19.41 BUSD | +3.12% | |
| 18.82 BUSD | +44.48% | |
| 13.03 BUSD | +12.15% | |
| 11.62 BUSD | +73.58% | |
| 6.69 BUSD | +3.43% | |
| 6.47 BUSD | +19.06% | |
| 5.44 BUSD | -11.08% | |
| 6.11 BUSD | +9.24% | |
| 5.60 BUSD | -26.68% | |
| 7.63 BUSD | +71.79% | |
| 4.44 BUSD | +40.91% | |
| 3.15 BUSD | -12.91% | |
| 3.62 BUSD | +62.00% | |
| 2.23 BUSD | -5.63% | |
| 2.37 BUSD | -22.60% | |
| 3.06 BUSD | +70.93% | |
| 1.79 BUSD | +16.73% | |
| 1.53 BUSD | +39.02% | |
| 1.10 BUSD | +10.53% | |
| 997.95 MUSD | — |
Merck & Co Stock analysis
Frequently Asked Questions about Merck & Co stock
Current Liabilities of Merck & Co is 28.33 B USD in 2026.
Current Liabilities of Merck & Co changed from 41.99 B USD to 28.33 B USD, representing a -32.53% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Merck & Co since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Merck & Co historically and in real time.
Balance Sheet — Merck & Co
All Key Metrics — Merck & Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth